Cosmetic Peptides for Receptor-Blocked Wrinkle Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing cosmetic treatments for wrinkles and expression lines, such as botulinum toxin, have limitations due to high toxicity, require frequent injections, and are not effective for wrinkles caused by mechanisms other than muscle contraction, while also posing risks and side effects.
Innovation Solution
Development of new peptides with specific amino acid sequences, such as Pro-Trp-Lys-Trp and Pal-Pro-Thr-Lys-Trp, that inhibit muscle contraction by blocking nicotinic acetylcholine receptors and provide antiperspirant effects, formulated in cosmetic, dermocosmetic, or pharmaceutical compositions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If botulinum toxin is used for muscle relaxation and wrinkle reduction, then wrinkle intensity is reduced, but toxicity and side effects increase
Solution Approach 1:
The patent extracts the functional mechanism of botulinum toxin (blocking acetylcholine release at neuromuscular junctions) and implements it through synthetic peptides that mimic this action without the toxic properties. The peptides selectively target nicotinic acetylcholine receptors, achieving muscle relaxation through the same physiological pathway as botulinum toxin but without its harmful effects.
Solution Approach 2:
The patent creates simplified copies of the botulinum toxin's mechanism of action using small peptide sequences (such as Pro-Trp-Lys-Trp and Pal-Pro-Thr-Lys-Trp) that replicate the receptor-blocking function. These peptide copies provide the desired therapeutic effect with significantly improved safety profiles.
2Duration of action of stationary object
If botulinum toxin injections are administered frequently to maintain wrinkle reduction, then wrinkle smoothing is sustained, but treatment complexity and frequency of application increase
Solution Approach 1:
The patent transitions from the dynamic injection-based administration of botulinum toxin to a static, sustained-action peptide formulation that can be applied topically and maintains effect over extended periods. The peptide designs incorporate structural features that enhance stability and prolong activity, reducing the need for frequent reapplication.
3Adaptability or versatility
If botulinum toxin is used for wrinkle treatment, then dynamic wrinkles are reduced, but it is not effective for wrinkles caused by mechanisms other than muscle contraction
Solution Approach 1:
The patent designs peptides with multiple functional capabilities: they block nicotinic acetylcholine receptors for muscle relaxation (treating dynamic wrinkles), while also providing skin protection and potential benefits for other wrinkle types through their interaction with skin cells and extracellular matrix. This multi-functional design allows the same peptide to address various wrinkle etiologies.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptides effectively reduce the intensity, area, and depth of wrinkles and expression lines, and provide temporary antiperspirant benefits with reduced side effects and frequency of application.
Implementation Method 1
The peptides effectively reduce the intensity, area, and depth of wrinkles and expression lines by blocking nicotinic acetylcholine receptors, thereby inhibiting the transmission of nerve impulses to muscle fibers and preventing muscle contraction
Data Source
AI summary
The present invention describes new compounds and compositions effective for relaxing muscles, including skeletal muscles of the face, for anti-aging cosmetic action, for reducing and/or smoothing expression lines and wrinkles and/or for antiperspirant action.